A package includes an outer sleeve and a slider for holding a blister pack slidably mounted within the outer sleeve. The outer sleeve includes a wall having an outer panel and an inner panel. The inner panel has a locking edge formed at a terminal end thereof spaced from and facing a closed end of the sleeve. A locking flap is formed at a terminal end of the slider extending in a direction away from a closed end of the outer sleeve for engagement with the said wall of the outer sleeve. The flap has a free edge for engagement with the locking edge of the inner panel to prevent the slider from being removed from the outer sleeve when the slider is fully received within the outer sleeve. The outer panel of the outer sleeve includes a release button at least partially overlapping the flap of the slider when the slider is fully inserted in the outer sleeve, and being pressable so as to disengage the free edge of the slider flap from the locking edge of the outer sleeve wall to permit the slider to be withdrawn from the outer sleeve.

The purpose of the present invention is to provide an absorbent layer for blister packs, which imparts sufficient formability and is free from forming failure even if a pocket part is formed to a certain depth. An absorbent layer for blister packs, which sequentially comprises, in the following order, an outer skin layer, an intermediate layer containing an inorganic absorbent and a binder resin, and an inner skin layer containing 5-80% by mass of a metallocene polypropylene and 95-20% by mass of a non-metallocene polypropylene.

The present disclosure provides a medication package. The medication package may include a first medication stored in a first cavity and a second medication stored in a second cavity. The first medication may be selected, based on a geographical region, from a group of classes of medications. The second medication may be selected, based on the geographical region, from a group of classes of medications, wherein the class of the second medication is different than that of the first medication. The geographical region may be a contiguous region and may be defined by a common attribute.

Systems and methods are disclosed for a medical pill dispensing system. A method involves accessing a plan. The plan indicates a first pill distribution for a first period of time, and a second pill distribution for a second period of time. The method also involves receiving an input, where the input indicates a change to the plan. The input indicates at least one pill to be distributed in the first period of time. The method also involves determining whether to modify one or more of the first pill distribution or the second pill distribution. The method involves, in response to a determination that the second pill distribution is to be modified, modifying the plan to indicate a change in the second pill distribution.

The present invention belongs to the field of pharmaceutical industry and relates to a dry pharmaceutical composition comprising Canagliflozin, as well as to a process for preparing the same. Such dry pharmaceutical composition is useful as a medicament, especially for the normalization of plasma glucose levels.

A blister and package system made of a blister card and an outer package with unique interacting locking mechanisms. The blister card or strip is inserted into the outer package or sleeve and locks immediately without having to further process the outer package or the blister card or strip. The user is able to expose the blisters from the outer package by disengaging the lock. The blister card or strip includes a formable, pliable sheet material, into which one or more individual cavities or blisters are formed. The separated cavities are loaded with product and sealed with one or more layers of puncturable or tearable sheet material, such as aluminum foil. The blister card or strip contains a plastic rivet assembly that forms an interference mechanism. The rivet is trapped by an internally formed panel and stopped by a catch flap included in the outer package.

A method and a medication organizer tray apparatus for organizing medications and collecting medication adherence information are provided. The medication organizer tray apparatus includes a support frame, multiple medication bins accommodating multiple medications, a bin cover layer with multiple customized bin labels, and a conductive circuit layer. The support frame includes multiple apertures positioned at predefined intervals from each other for placement of the medication bins. The customized bin labels having medical information printed thereon seal openings of the medication bins. The conductive circuit layer includes conductive lines running along one or more of a lower surface of the bin cover layer, around each medication bin, and a lower surface of each medication bin. The conductive circuit layer electrically communicates with a receptacle base to enable detection of removal of each medication bin from the support frame and detection of tampering of the medication bins.

The invention relates to an installation and a method for repackaging different medicines from their respective original blister packs into organiser blister packs, in particular weekly blister packs for an individual patient having receiving compartments arranged in a matrix configuration with rows corresponding to a number of times medicines are to be taken over the course of a day and columns corresponding to a number of days, for example days of the week. The installation proposed by the invention has a conveying device for singulating and conveying filled original blister packs, an intermediate storage facility with random access for intermediate storage of the original blister packs packed in blister pack supports of standard external dimensions assigned to a respective original blister pack type, and an ejection device for ejecting a defined number of units of a selected medicine from the respective original blister pack into the organiser blister pack.

The present invention relates to a blister pack for pharmaceutical compositions or supplements.

Described are solid pharmaceutical compositions of fusidic acid, and pharmaceutically acceptable salts thereof, dosage units of the pharmaceutical compositions, and packages for pharmaceutical compositions of fusidic acid, and pharmaceutically acceptable salts thereof, which increase stability against the degradation of the fusidic acid, and pharmaceutically acceptable salts thereof. Also described are uses of the pharmaceutical compositions and dosage units in treating diseases.